Search results
GSK Concealed Risk Associated With Discontinued Heart Burn Drug Zantac, Whistleblower Lawsuit Claims
Benzinga via Yahoo Finance· 4 days agoGSK Plc (NYSE:GSK) has been reportedly sued by an independent Connecticut laboratory, Valisure,...
GSK’s Potential Blockbuster Asthma Drug Shows Promise in Latest Trial
The Wall Street Journal· 4 days agoHEALTH NEWS GSK’s experimental drug for asthma met its goals in the latest trial, moving a treatment...
Q3 2024 EPS Estimates for GSK plc Boosted by Zacks Research (NYSE:GSK)
ETF DAILY NEWS· 1 day agoGSK plc (NYSE:GSK – Free Report) – Analysts at Zacks Research increased their Q3 2024 earnings estimates for shares of GSK in a note ...
GSK Plc ADR (GSK): Worth A Small Bite At $45.15 – Stocks Register
Stocks Register· 1 day agoGSK Plc ADR (NYSE:GSK) concluded the trading at $45.15 on Thursday, May 23 with a fall of -1.38% from its closing price on previous day. Taking a look at ...
GSK found not guilty in Zantac trial
Proactive Investors· 1 day agoBritish pharmaceuticals big cap GSK PLC (LSE:GSK, NYSE:GSK) has won a high-stake personal injury case in the state of Illinois, US, over its heartburn...
Independent Advisor Alliance Has $740,000 Position in GSK plc (NYSE:GSK)
ETF DAILY NEWS· 4 days agoIndependent Advisor Alliance decreased its position in GSK plc (NYSE:GSK – Free Report) by 8.9% in the 4th quarter, according to the company in its most ...
...Finds No Link To Colon Cancer In Initial Trial, GSK And Boehringer Prevail In First Zantac Cancer...
Benzinga via Yahoo Finance· 16 hours agoThe jury in Cook County, Illinois, found that Angela Valadez, an 89-year-old Illinois resident, did...
Cancer Biotech Stocks Are on the Move Ahead of a Big Event. What to Know.
Barrons.com· 20 hours agoThe American Society of Clinical Oncology is set to gather on May 31 in Chicago for its annual...
GSK’s New Vaccine Kept the Boss in Her Job — and an Activist at Bay
Bloomberg via Yahoo Finance· 4 days ago(Bloomberg) -- When Elliott Investment Management came calling for the ouster of Emma Walmsley, the...
GSK’s asthma drug shows promise in reducing severe attacks
WSAU Wausau· 4 days ago(Reuters) - GSK's asthma drug met its primary goal of reducing asthma attacks over a 52-week period...